![](/img/cover-not-exists.png)
111 Final results of a multi-center phase 1b, randomized, placebo-controlled, doseescalation trial of CPG 10101 in patients with chronic hepatitis C virus
J.G. McHutchison, B.R. Bacon, S.C. Gordon, E. Lawitz, M. Shiffman, N.H. Afdhal, I.M. Jacobson, A. Muir, A. Vicari, S. Efler, M. Al-Adhami, M.L. Morris, H.L. DavisVolume:
44
Year:
2006
Language:
english
DOI:
10.1016/s0168-8278(06)80112-1
File:
PDF, 94 KB
english, 2006